Motus GI Scheduled to Participate in the Piper Sandler 32nd Annual Healthcare Conference
Motus GI Holdings, Inc. (NASDAQ: MOTS) has announced its participation in the Piper Sandler 32nd Annual Healthcare Conference, happening virtually from December 1-3, 2020.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Motus GI Holdings, Inc. (NASDAQ: MOTS) has announced its participation in the Piper Sandler 32nd Annual Healthcare Conference, happening virtually from December 1-3, 2020. CEO Tim Moran will engage in a fireside chat available for webcast from November 25 to December 3. Additionally, the management team will hold 1x1 meetings on December 2, exclusively via Piper Sandler. Motus GI specializes in endoscopy solutions aimed at improving clinical outcomes and cost-efficiency in gastrointestinal diagnostics.
Details
News Market Reaction – MOTS
The recorded move for MOTS in the trading session of this news was +0.75%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FORT LAUDERDALE, Fla., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that its management team is scheduled to participate in the Piper Sandler 32nd Annual Healthcare Conference, which is scheduled to take place virtually from December 1-3, 2020.
Tim Moran, Chief Executive Officer of Motus GI, will participate in a fireside chat that will be available via webcast on the Piper Sandler conference site (click here) from November 25th to December 3rd, and on the Events page on the Company’s website, www.motusgi.com. An archive of the webcast will continue to be available on the Company’s website for 90 days.
In addition, the Motus GI management team will be participating in 1x1 meetings on December 2, 2020, meetings may be requested exclusively via Piper Sandler.
About Motus GI
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.
For more information, visit www.motusgi.com and connect with the Company on Twitter, LinkedIn and Facebook.
Investor Contact:
Bob Yedid
LifeSci Advisors
(646) 597-6989
bob@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.